Join the event trusted by enterprise leaders for nearly two decades. VB Transform brings together the people building real enterprise AI strategy. Learn more Researchers from Stanford University‘s ...
Over decades, antibodies have established themselves as a key therapeutic modality for a wide range of diseases. But antibodies as they are found in nature did not evolve to be used as drugs, says ...
Chronicling the Seattle and Pacific Northwest startup scene. SEE MORE by Alan Boyle on Oct 30, 2024 at 4:10 am October 30, 2024 at 5:09 am Archon Biosciences’ co-founders, James Lazarovits and George ...
Antibody Cages (AbCs) are a new class of biologic medicines that precisely orient antibodies in novel geometric configurations not found in nature. This new design space preserves the proven binding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results